Pneumococcal Vaccine in Australia

The making of a DNA vaccine. (Photo credit: Wikipedia)

Source: Australian Prescriber - June 2013 - Acess to full text.

Summary

Universal vaccination of Australian children with the 7-valent pneumococcal conjugate since 2005 has substantially reduced invasive pneumococcal disease. Herd immunity has also been observed in
adults.
Conjugate vaccines of higher valency, which provide additional serotype coverage, became available in 2009. The 13-valent vaccine replaced the 7-valent vaccine in the National Immunisation Program
in July 2011.
The 23-valent polysaccharide vaccine is recommended for all adults aged 65 years or over and for Aboriginal and Torres Strait Islander adults aged 50 years or over. It is also indicated in younger
people with risk factors for invasive disease.
Additional pneumococcal vaccine doses are recommended for children and adults at increased risk of invasive disease.
The Australian Immunisation Handbook 10th edition contains detailed recommendations.

Related articles

• Genome sequencing provides unprecedented insight into causes of pneumococcal disease
• New Pneumococcal Vaccine as Safe as Previous Version of the Vaccine
• Unprecedented Insight Into Causes Of Pneumococcal Disease Offered By Genome Sequencing
• Doctors Health Press Reports on Study: Virus' Reaction to Vaccine Discovered Using Genome Sequencing
• New Pneumococcal Vaccine Appears To Be As Safe As Previously Used Vaccine
• New pneumococcal vaccine as safe as previous version
• Immunisation reduces child mortality
• FDA Expands use of Pneumococcal Vaccine
• Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
• Uganda: Immunization - Parents to Face Arrest.